NORMACELL Trademark

Trademark Overview


On Thursday, January 17, 2019, a trademark application was filed for NORMACELL with the United States Patent and Trademark Office. The USPTO has given the NORMACELL trademark a serial number of 79252372. The federal status of this trademark filing is REGISTERED as of Tuesday, November 19, 2019. This trademark is owned by VITALIS PHARMA GmbH. The NORMACELL trademark is filed in the Pharmaceutical Products category with the following description:

[ Pharmaceutical preparations for the prevention of cell alterations by oxidative stress; medicines for human use, namely, medicinal preparation for normal function of the immune system and protection of cells from oxidative stress; Dietetic substances, namely, Dietetic foods and beverages adapted for medical use, food supplements and dietetic preparations in the form of capsules or tablets, adapted for medical use for treatment of disfunctional immune system; medicinal plants extracts for pharmaceutical use; Vitamin and mineral supplements; Decoctions for pharmaceutical purposes for the treatment of disfunctional immune system; medical plant extracts; dried or preserved medical plants, namely, plant extracts for pharmaceutical purposes ] * Dietary supplement consisting of peptides of porcine spleen proteins and selenium, which contributes to the normal functioning of the immune system and to the protection of cells against oxidative stress *
normacell

General Information


Serial Number79252372
Word MarkNORMACELL
Filing DateThursday, January 17, 2019
Status700 - REGISTERED
Status DateTuesday, November 19, 2019
Registration Number5911244
Registration DateTuesday, November 19, 2019
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, September 3, 2019

Trademark Statements


Certificate of Correction for Registration In the statement, " International Class 5 " is corrected per the Restriction and the fnote dated 12/18/2019
Goods and Services[ Pharmaceutical preparations for the prevention of cell alterations by oxidative stress; medicines for human use, namely, medicinal preparation for normal function of the immune system and protection of cells from oxidative stress; Dietetic substances, namely, Dietetic foods and beverages adapted for medical use, food supplements and dietetic preparations in the form of capsules or tablets, adapted for medical use for treatment of disfunctional immune system; medicinal plants extracts for pharmaceutical use; Vitamin and mineral supplements; Decoctions for pharmaceutical purposes for the treatment of disfunctional immune system; medical plant extracts; dried or preserved medical plants, namely, plant extracts for pharmaceutical purposes ] * Dietary supplement consisting of peptides of porcine spleen proteins and selenium, which contributes to the normal functioning of the immune system and to the protection of cells against oxidative stress *
Pseudo MarkNORMA CELL

Classification Information


International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateTuesday, February 26, 2019
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NameNOT AVAILABLE
Party Type30 - Original Registrant
Legal Entity Type01 - Individual
AddressBG

Party NameNOT AVAILABLE
Party Type20 - Owner at Publication
Legal Entity Type01 - Individual
AddressBG

Party NameNOT AVAILABLE
Party Type11 - New Owner Before Publication
Legal Entity Type01 - Individual
AddressBG

Party NameVITALIS PHARMA GmbH
Party Type10 - Original Applicant
Legal Entity Type27 - NOT AVAILABLE
AddressCH

Trademark Events


Event DateEvent Description
Friday, October 2, 2020INVALIDATION REVIEWED - NO ACTION REQUIRED BY OFFICE
Wednesday, September 9, 2020PARTIAL INVALIDATION OF REG EXT PROTECTION CREATED
Friday, April 3, 2020FINAL DECISION TRANSACTION PROCESSED BY IB
Saturday, March 14, 2020FINAL DISPOSITION NOTICE SENT TO IB
Saturday, March 14, 2020FINAL DISPOSITION PROCESSED
Wednesday, February 19, 2020FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
Thursday, January 9, 2020LIMITATION FROM THE IB EXAMINED AND ENTERED
Thursday, January 9, 2020CORRECTION UNDER SECTION 7 ¿ PROCESSED
Thursday, January 9, 2020CASE ASSIGNED TO POST REGISTRATION PARALEGAL
Tuesday, November 19, 2019REGISTERED-PRINCIPAL REGISTER
Friday, November 1, 2019LIMITATION OF GOODS RECEIVED FROM IB
Tuesday, September 3, 2019PUBLISHED FOR OPPOSITION
Friday, August 30, 2019NOTIFICATION PROCESSED BY IB
Wednesday, August 14, 2019NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
Wednesday, August 14, 2019NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB
Wednesday, August 14, 2019NOTICE OF PUBLICATION
Tuesday, July 30, 2019ASSIGNED TO LIE
Monday, July 22, 2019APPROVED FOR PUB - PRINCIPAL REGISTER
Tuesday, July 2, 2019TEAS/EMAIL CORRESPONDENCE ENTERED
Tuesday, July 2, 2019CORRESPONDENCE RECEIVED IN LAW OFFICE
Tuesday, July 2, 2019TEAS REQUEST FOR RECONSIDERATION RECEIVED
Monday, June 24, 2019FINAL REFUSAL MAILED
Thursday, June 20, 2019FINAL REFUSAL WRITTEN
Saturday, June 1, 2019REFUSAL PROCESSED BY IB
Monday, May 27, 2019TEAS/EMAIL CORRESPONDENCE ENTERED
Monday, May 27, 2019CORRESPONDENCE RECEIVED IN LAW OFFICE
Monday, May 27, 2019TEAS RESPONSE TO OFFICE ACTION RECEIVED
Thursday, May 23, 2019CHANGE OF OWNER RECEIVED FROM IB
Thursday, April 25, 2019NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
Thursday, April 25, 2019REFUSAL PROCESSED BY MPU
Thursday, April 4, 2019NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Wednesday, April 3, 2019NON-FINAL ACTION WRITTEN
Friday, March 29, 2019ASSIGNED TO EXAMINER
Saturday, March 2, 2019APPLICATION FILING RECEIPT MAILED
Tuesday, February 26, 2019NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM
Thursday, February 21, 2019SN ASSIGNED FOR SECT 66A APPL FROM IB